The effect of renal denervation on kidney oxygenation as determined by BOLD MRI in patients with hypertension

European Radiology

Volumn 25, Issue 7, 2015, Pages 1984-1992

  Vink, E E ^a   Boer, A ^a   Verloop, W L ^a   Spiering, W ^a   Voskuil, M ^a   Vonken, E ^a   Hoogduin, J M ^a   Leiner, T ^a   Bots, M L ^a   Blankestijn, P J ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

Blood oxygen level dependent MRI; Hypertension; Kidneys; Renal denervation; Renal oxygenation

Indexed keywords

ANTIHYPERTENSIVE AGENT; DOXAZOSIN; SODIUM; OXYGEN;

ADULT; ANTIHYPERTENSIVE THERAPY; ARTICLE; BOLD SIGNAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DRUG SUBSTITUTION; DRUG WITHDRAWAL; FEMALE; FOLLOW UP; GLOMERULUS FILTRATION RATE; HUMAN; INVESTIGATIVE PROCEDURES; KIDNEY DENERVATION; KIDNEY OXYGENATION; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RESISTANT HYPERTENSION; SODIUM EXCRETION; SYSTOLIC BLOOD PRESSURE; THERAPY EFFECT; TISSUE OXYGENATION; BLOOD; BLOOD PRESSURE; BLOOD PRESSURE MONITORING; BREATHING; HYPERTENSION; INNERVATION; KIDNEY; MIDDLE AGED; PATHOPHYSIOLOGY; PHYSIOLOGY; PROCEDURES; PROSPECTIVE STUDY; SYMPATHECTOMY; YOUNG ADULT;

BLOOD PRESSURE; BLOOD PRESSURE MONITORING, AMBULATORY; FEMALE; GLOMERULAR FILTRATION RATE; HUMANS; HYPERTENSION; KIDNEY; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; OXYGEN; PROSPECTIVE STUDIES; RESPIRATION; SYMPATHECTOMY; YOUNG ADULT;

EID: 84930478449     PISSN: 09387994     EISSN: 14321084     Source Type: Journal    
DOI: 10.1007/s00330-014-3583-1     Document Type: Article

References (26)

1. Welch WJ (2006) Intrarenal oxygen and hypertension. Clin Exp Pharmacol Physiol 33:1002–1005
2. Ye S, Gamburd M, Mozayeni P, Koss M, Campese VM (1998) A limited renal injury may cause a permanent form of neurogenic hypertension. Am J Hypertens 11:723–728
3. Krum H, Schlaich M, Whitbourn R, Sobotka PA, Sadowski J, Bartus K, Kapelak B, Walton A, Sievert H, Thambar S, Abraham WT, Esler M (2009) Catheter-based renal sympathetic denervation for resistant hypertension: a multicentre safety and proof-of-principle cohort study. Lancet 373:1275–1281
4. Esler MD, Krum H, Sobotka PA, Schlaich MP, Schmieder RE, Bohm M (2010) Renal sympathetic denervation in patients with treatment-resistant hypertension (The Symplicity HTN-2 Trial): a randomised controlled trial. Lancet 376:1903–1909
5. Symplicity HTN-1 Investigators (2011) Catheter-based renal sympathetic denervation for resistant hypertension: durability of blood pressure reduction out to 24 months. Hypertension 57:911–917
6. Li LP, Halter S, Prasad PV (2008) Blood oxygen level-dependent MR imaging of the kidneys. Magn Reson Imaging Clin N Am 16:613–625
7. Heyman SN, Khamaisi M, Rosen S, Rosenberger C (2008) Renal parenchymal hypoxia, hypoxia response and the progression of chronic kidney disease. Am J Nephrol 28:998–1006
8. Verloop WL, Vink EE, Voskuil M, Vonken EJ, Rookmaaker MB, Bots ML, Doevendans PA, Blankestijn PJ, Spiering W (2013) Eligibility for percutaneous renal denervation: the importance of a systematic screening. J Hypertens 31:1662–1668
9. Funder JW, Carey RM, Fardella C, Gomez-Sanchez CE, Mantero F, Stowasser M, Young WF Jr, Montori VM (2008) Case detection, diagnosis, and treatment of patients with primary aldosteronism: an endocrine society clinical practice guideline. J Clin Endocrinol Metab 93:3266–3281
10. Shionoiri H, Yasuda G, Yoshimura H, Umemura S, Miyajima E, Miyakawa T, Takagi N, Kaneko Y (1987) Antihypertensive effects and pharmacokinetics of single and consecutive administration of doxazosin in patients with mild to moderate essential hypertension. J Cardiovasc Pharmacol 10:90–95
11. Ebrahimi B, Gloviczki M, Woollard JR, Crane JA, Textor SC, Lerman LO (2012) Compartmental analysis of renal BOLD MRI data: introduction and validation. Invest Radiol 47:175–182
12. Schlaich MP, Sobotka PA, Krum H, Lambert E, Esler MD (2009) Renal sympathetic-nerve ablation for uncontrolled hypertension. N Engl J Med 361:932–934
13. Worthley SG, Tsioufis CP, Worthley MI, Sinhal A, Chew DP, Meredith IT, Malaiapan Y, Papademetriou V (2013) Safety and efficacy of a multi-electrode renal sympathetic denervation system in resistant hypertension: the EnligHTN I trial. Eur Heart J 34:2132–2140
14. Ormiston JA, Watson T, Van PN, Stewart R, Haworth P, Stewart JT, Webster MW (2013) First-in-human use of the OneShot renal denervation system from Covidien. EuroIntervention 8:1090–1094
15. Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF III, Feldman HI, Kusek JW, Eggers P, Van LF, Greene T, Coresh J (2009) A new equation to estimate glomerular filtration rate. Ann Intern Med 150:604–612
16. Ott C, Janka R, Schmid A, Titze S, Ditting T, Sobotka PA, Veelken R, Uder M, Schmieder RE (2013) Vascular and Renal Hemodynamic Changes after Renal Denervation. Clin J Am Soc Nephrol
17. Mahfoud F, Cremers B, Janker J, Link B, Vonend O, Ukena C, Linz D, Schmieder R, Rump LC, Kindermann I, Sobotka PA, Krum H, Scheller B, Schlaich M, Laufs U, Bohm M (2012) Renal Hemodynamics and Renal Function After Catheter-Based Renal Sympathetic Denervation in Patients With Resistant Hypertension. Hypertension
18. Prasad PV (2006) Evaluation of intra-renal oxygenation by BOLD MRI. Nephron Clin Pract 103:c58–c65
19. Waeber B, Brunner HR (1999) Clinical value of ambulatory blood pressure monitoring in the assessment of antihypertensive therapy. Blood Press Monit 4:263–266
20. Mancia G, Fagard R, Narkiewicz K, Redon J, Zanchetti A, Bohm M, Christiaens T, Cifkova R, De BG, Dominiczak A, Galderisi M, Grobbee DE, Jaarsma T, Kirchhof P, Kjeldsen SE, Laurent S, Manolis AJ, Nilsson PM, Ruilope LM, Schmieder RE, Sirnes PA, Sleight P, Viigimaa M, Waeber B, Zannad F (2013) 2013 ESH/ESC Guidelines for the management of arterial hypertension: The Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens 31:1281–1357
21. Mahfoud F, Ukena C, Schmieder RE, Cremers B, Rump LC, Vonend O, Weil J, Schmidt M, Hoppe UC, Zeller T, Bauer A, Ott C, Blessing E, Sobotka PA, Krum H, Schlaich M, Esler M, Bohm M (2013) Ambulatory blood pressure changes after renal sympathetic denervation in patients with resistant hypertension. Circulation 128:132–140
22. Gloviczki ML, Glockner JF, Lerman LO, McKusick MA, Misra S, Grande JP, Textor SC (2010) Preserved oxygenation despite reduced blood flow in poststenotic kidneys in human atherosclerotic renal artery stenosis. Hypertension 55:961–966
23. Textor SC, Glockner JF, Lerman LO, Misra S, McKusick MA, Riederer SJ, Grande JP, Gomez SI, Romero JC (2008) The use of magnetic resonance to evaluate tissue oxygenation in renal artery stenosis. J Am Soc Nephrol 19:780–788
24. Epstein FH, Prasad P (2000) Effects of furosemide on medullary oxygenation in younger and older subjects. Kidney Int 57:2080–2083
25. Djamali A, Sadowski EA, Muehrer RJ, Reese S, Smavatkul C, Vidyasagar A, Fain SB, Lipscomb RC, Hullett DH, Samaniego-Picota M, Grist TM, Becker BN (2007) BOLD-MRI assessment of intrarenal oxygenation and oxidative stress in patients with chronic kidney allograft dysfunction. Am. J. Physiol Renal Physiol 292:F513–F522
26. Siddiqi L, Hoogduin H, Visser F, Leiner T, Mali WP, Blankestijn PJ (2014) Inhibition of the renin-angiotensin system affects kidney tissue oxygenation evaluated by magnetic resonance imaging in patients with chronic kidney disease. J Clin Hypertens 16:214–218